These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 12348212)

  • 1. New year, new option: Cyclo-Provera awaits word.
    Contracept Technol Update; 1998 Jan; 19(1):3-4. PubMed ID: 12348212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA board investigates Depo-Provera safety.
    Contracept Technol Update; 1983 Mar; 4(3):25-7. PubMed ID: 12266161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
    Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA advisory panel recommends approval for Depo-Provera.
    Contracept Technol Update; 1992 Oct; 13(10):159-60. PubMed ID: 12344726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Not FDA-approved, but experts recommend Depo-Provera.
    Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depo-Provera highly effective as injectable contraceptive.
    Denniston GC
    Contracept Technol Update; 1985 Dec; 6(12):167-8. PubMed ID: 12280301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable contraception: the USA perspective.
    Kaunitz AM
    IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The wait for a monthly combined hormonal injectable may be over soon.
    Contracept Technol Update; 1999 Nov; 20(11):125-7. PubMed ID: 12295326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicians clash with consumer groups over possible Depo ban.
    Contracept Technol Update; 1995 Jan; 16(1):11-4. PubMed ID: 12319319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclofem shoots into injectable market.
    Family Plan World; 1992; ():19. PubMed ID: 12290896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
    Greenspan A
    Contracept Technol Update; 1981 Mar; 2(3):35-6. PubMed ID: 12337540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depo Provera: still controversial.
    Wren LM
    Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversy over Depo-Provera.
    Wash Drug Device Lett; 1977 Jan; 9(1):2. PubMed ID: 12335988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USAID negotiating Depo purchase, but shelf life proves problematic.
    Family Plan World; 1993; 3(4):7, 21. PubMed ID: 12288090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicolegal issues surrounding Depo-Provera easily overcome.
    Contracept Technol Update; 1992 Jan; 13(1):16, 18. PubMed ID: 12343460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Millions of couples to have choice of injectable contraceptive.
    Integration; 1996; (47):41. PubMed ID: 12347310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depo-Provera: costs eat up clinic contraceptive budgets.
    Contracept Technol Update; 1999 Jan; 20(1):1-3. PubMed ID: 12349019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive research: still inadequate after all these years?
    Diconsiglio JM
    Family Plan World; 1992; 2(6):14. PubMed ID: 12344623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of three-monthly injectable contraceptive DMPA not linked to breast cancer.
    Entre Nous Cph Den; 1996 May; (32):11. PubMed ID: 12222270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA review panel gives thumbs up to Norplant.
    Wash Memo Alan Guttmacher Inst; 1989 May; ():3-5. PubMed ID: 12290752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.